Care of vision and ocular health in diabetic members of a national diabetes organization: A cross-sectional study

BMC Health Services Research

Volumn 8, Issue , 2008, Pages

  Sundling, Vibeke ^a   Gulbrandsen, Pål ^b   Jervell, Jak ^c   Straand, Jørund ^d  

^a UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c NONE   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; CONFIDENCE INTERVAL; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE DURATION; EYE DISEASE; EYE EXAMINATION; FEMALE; HEALTH CARE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL RESEARCH; NORWAY; PRACTICE GUIDELINE; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; SYMPTOM; VISION; BLOOD; CROSS-SECTIONAL STUDY; HEALTH SURVEY; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; UTILIZATION REVIEW; VISION TEST; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEALTH STATUS INDICATORS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NORWAY; PREVALENCE; QUESTIONNAIRES; VISION DISORDERS; VISION TESTS;

EID: 50249154845     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-8-159     Document Type: Article

References (36)

1. Diabetic retinopathyA clinical update. M Porta F Bandello, Diabetologia 2002 45 12 1617 1634 10.1007/s00125-002-0990-7 12488951
2. Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. H Buch T Vinding M La Cour M Appleyard GB Jensen NV Nielsen, Ophthalmology 2004 111 1 53 61 10.1016/j.ophtha.2003.05.010 14711714
3. Causes of blindness and visual impairment in the West of Scotland. MA Bamashmus B Matlhaga GN Dutton, Eye 2004 18 3 257 261 10.1038/sj.eye.6700606 15004574
4. Diabetic eye complications in a medium sized municipality in southwest Norway. R Hapnes H Bergrem, Acta Ophthalmol Scand 1996 74 5 497 500 8950402
5. A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients. G Joner O Brinchmann-Hansen CG Torres KF Hanssen, Diabetologia 1992 35 11 1049 1054 10.1007/BF02221680 1473614
6. [Prevalence of diabetes mellitus in Norway.]. LC Stene K Midthjell AK Jenum S Skeie KI Birkeland E Lund G Joner GS Tell H Schirmer, Tidsskr Nor Laegeforen 2004 124 11 1511 1514 15195154
7. Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. N Younis DM Broadbent SP Harding JR Vora, Diabet Med 2002 19 12 1014 1021 10.1046/j.1464-5491.2002.00854.x 12647843
8. Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study. T Skrivarhaug DS Fosmark LC Stene HJ Bangstad L Sandvik KF Hanssen G Joner, Diabetologia 2006 49 10 2281 2290 10.1007/s00125-006-0364-7 16955208
9. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linkoping Diabetes Complications Study. M Nordwall M Bojestig HJ Arnqvist J Ludvigsson, Diabetologia 2004 47 7 1266 1272 10.1007/s00125-004-1431-6 15235773
10. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. P Hovind L Tarnow K Rossing P Rossing S Eising N Larsen C Binder HH Parving, Diabetes Care 2003 26 4 1258 1264 10.2337/diacare.26.4.1258 12663607
11. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). M Henricsson L Nystrom G Blohme J Ostman C Kullberg M Svensson A Scholin HJ Arnqvist E Bjork J Bolinder JW Eriksson G Sundkvist, Diabetes Care 2003 26 2 349 354 10.2337/diacare.26.2.349 12547861
12. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. L Cikamatana P Mitchell E Rochtchina S Foran JJ Wang, Eye 2007 21 4 465 471 17318200
13. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. N Younis DM Broadbent JP Vora SP Harding, Lancet 2003 361 9353 195 200 10.1016/S0140- 6736(03)12267-2 12547541
14. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. IM Stratton EM Kohner SJ Aldington RC Turner RR Holman SE Manley DR Matthews, Diabetologia 2001 44 2 156 163 10.1007/s001250051594 11270671
15. Leading causes of certification for blindness and partial sight in England & Wales. C Bunce R Wormald, BMC Public Health 2006 6 58 16524463 10.1186/1471-2458-6-58
16. Trends in blind registration in the adult population of the Republic of Ireland 1996-2003. C Kelliher D Kenny C O'Brien, Br J Ophthalmol 2006 90 3 367 371 10.1136/bjo.2005.075861 16488964
17. [Epidemiology of blindness in Baden, Germany]. K Rohrschneider S Greim, Klin Monatsbl Augenheilkd 2004 221 2 116 121 10.1055/s-2004-812724 14986210
18. Diabetic retinopathy. LP Aiello TW Gardner GL King G Blankenship JD Cavallerano FL Ferris 3rd R Klein, Diabetes Care 1998 21 1 143 156 9538986
19. New blindness in diabetes reduced by more than one-third in Stockholm County. LB Backlund PV Algvere U Rosenqvist, Diabet Med 1997 14 9 732 740 10.1002/(SICI)1096-9136(199709)14:9<732::AID-DIA474>3.0.CO;2-J 9300222
20. Active prevention in diabetic eye disease. A 4-year follow-up. JK Kristinsson H Hauksdottir E Stefansson F Jonasson I Gislason, Acta Ophthalmol Scand 1997 75 3 249 254 9253967
21. Screening and prevention of diabetic blindness. E Stefansson T Bek M Porta N Larsen JK Kristinsson E Agardh, Acta Ophthalmol Scand 2000 78 4 374 385 10.1034/j.1600-0420.2000.078004374.x 10990036
22. Screening compliance and visual outcome in diabetes. GM Zoega T Gunnarsdottir S Bjornsdottir AB Hreietharsson G Viggosson E Stefansson, Acta Ophthalmol Scand 2005 83 6 687 690 10.1111/j.1600-0420.2005.00541.x 16396645
23. Cost-effectiveness of detecting and treating diabetic retinopathy. JC Javitt LP Aiello, Ann Intern Med 1996 124 1 Pt 2 164 169 8554212
24. [NSAMs guidelines for diabetes in general practice 2005. Short version]. T Claudi JG Cooper K Midthjell C Daae K Furuseth KF Hanssen, Norsk selskap for allmennmedisin, Den norske Lægeforening, Norges Diabetesforbund 2005
25. [Diabetic care in Norwegian general practice. A report of current status from Salten and some regions in Rogaland]. T Claudi J Cooper K Skogoy MF Hausken H Melbye, Tidsskr Nor Laegeforen 1997 117 25 3661 3664 9417661
26. [NSAMs guidelines for diabetes in general practice. Short version]. T Claudi JG Cooper K Midthjell C Daae K Furuseth KF Hanssen, Norsk selskap for allmennmedisin, Den norske Lægeforening, Norges Diabetesforbund 2000
27. Diabetes care in an Australian population: frequency of screening examinations for eye and foot complications of diabetes. RJ Tapp PZ Zimmet CA Harper MP de Courten B Balkau DJ McCarty HR Taylor TA Welborn JE Shaw, Diabetes Care 2004 27 3 688 693 10.2337/diacare.27.3.688 14988286
28. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. JB Saaddine B Cadwell EW Gregg MM Engelgau F Vinicor G Imperatore KM Narayan, Ann Intern Med 2006 144 7 465 474 16585660
29. Factors associated with regular eye examinations in people with diabetes: results from the Victorian Population Health Survey. A Muller E Lamoureux C Bullen JE Keeffe, Optom Vis Sci 2006 83 2 96 101 10.1097/01.opx.0000200678. 77515.2e 16501411
30. Coverage in screening for diabetic retinopathy according to screening provision: results from a national survey in England and Wales. A Wilson R Baker J Thompson G Grimshaw, Diabet Med 2004 21 3 271 278 10.1111/j.1464-5491.2004. 01131.x 15008839
31. Changes in eye care utilization following an eye health promotion campaign. A Muller JE Keeffe HR Taylor, Clin Experiment Ophthalmol 2007 35 4 305 309 10.1111/j.1442-9071.2007.01450.x 17539780
32. The validity of self-reported diabetes quality of care measures. JB Fowles K Rosheim EJ Fowler C Craft L Arrichiello, Int J Qual Health Care 1999 11 5 407 412 10.1093/intqhc/11.5.407 10561032
33. Optometric practice in Norway: a cross-sectional nationwide study. V Sundling P Gulbrandsen R Bragadottir LS Bakketeig J Jervell J Straand, Acta Ophthalmol Scand 2007 85 6 671 676 10.1111/j.1600-0420.2007.00929.x 17408386
34. The North Jutland County Diabetic Retinopathy Study: population characteristics. LL Knudsen HH Lervang S Lundbye-Christensen A Gorst-Rasmussen, Br J Ophthalmol 2006 90 11 1404 1409 10.1136/bjo.2006.093393 16825278
35. The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. MN Hove JK Kristensen T Lauritzen T Bek, Acta Ophthalmol Scand 2004 82 4 443 448 10.1111/j.1600-0420.2004.00270.x 15291939
36. Prevention and early detection of vascular complications of diabetes. SM Marshall A Flyvbjerg, BMJ 2006 333 7566 475 480 16946335 10.1136/bmj.38922. 650521.80